Analystreport

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) was upgraded by analysts at Janney Montgomery Scott from a "neutral" rating to a "buy" rating.

Supernus Pharmaceuticals, Inc.  (SUPN) 
Last supernus pharmaceuticals, inc. earnings: 2/25 04:40 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.supernus.com